NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.
Símbolo de cotizaciónNPCE
Nombre de la empresaNeuropace Inc
Fecha de salida a bolsaApr 22, 2021
Director ejecutivoMr. Joel D. Becker
Número de empleados184
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección455 N. Bernardo Avenue
CiudadMOUNTAIN VIEW
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal94043
Teléfono16502372700
Sitio Webhttps://www.neuropace.com/
Símbolo de cotizaciónNPCE
Fecha de salida a bolsaApr 22, 2021
Director ejecutivoMr. Joel D. Becker
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos